Financial reports
Current reports
8-K
Ginkgo Bioworks Completes Acquisition of Zymergen
19 Oct 22
8-K
Submission of Matters to a Vote of Security Holders
17 Oct 22
8-K
Other Events
12 Oct 22
8-K
Cost Associated with Exit or Disposal Activities
25 Aug 22
8-K
Ginkgo to Acquire Zymergen
25 Jul 22
8-K
Submission of Matters to a Vote of Security Holders
3 Jun 22
8-K
Zymergen Reports Preliminary First Quarter 2022 Financial Results
12 May 22
8-K
Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
22 Mar 22
8-K
Other Events
8 Mar 22
8-K
Departure of Directors or Certain Officers
3 Mar 22
Registration and prospectus
15-12G
Securities registration termination
31 Oct 22
POS AM
Prospectus update (post-effective amendment)
19 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Oct 22
25-NSE
Exchange delisting
19 Oct 22
425
Business combination disclosure
17 Oct 22
425
Business combination disclosure
12 Oct 22
425
Business combination disclosure
25 Aug 22
425
Business combination disclosure
16 Aug 22
425
Business combination disclosure
15 Aug 22
Other
EFFECT
Notice of effectiveness
26 Oct 22
EFFECT
Notice of effectiveness
8 Jun 22
EFFECT
Notice of effectiveness
22 Apr 21
CERT
Certification of approval for exchange listing
21 Apr 21
CORRESP
Correspondence with SEC
19 Apr 21
CORRESP
Correspondence with SEC
19 Apr 21
CORRESP
Correspondence with SEC
6 Apr 21
CORRESP
Correspondence with SEC
26 Mar 21
UPLOAD
Letter from SEC
22 Mar 21
UPLOAD
Letter from SEC
22 Feb 21
Ownership
SC 13G/A
SB INVESTMENT ADVISERS (UK) LTD
21 Oct 22
4
Change in insider ownership
21 Oct 22
4
JAY T FLATLEY
19 Oct 22
4
Steven Chu
19 Oct 22
4
SANDRA E PETERSON
19 Oct 22
4
Travis Murdoch
19 Oct 22
4
Christine Marie Gorjanc
19 Oct 22
4
Rohit Sharma
19 Oct 22
4
Matthew Ocko
19 Oct 22
4
Enakshi Singh
19 Oct 22